CARDIAC TOXICITY OF 5-FLUOROURACIL - 2 CASES

被引:0
|
作者
SAMOUN, M
POTOCKA, AC
PILLIERE, R
DELORME, G
PRINSEAU, J
BAGLIN, A
机构
[1] HOP AMBROISE PARE,SERV MED INTERNE & NEPHROL,9 AVE CHARLES DEGAULLE,F-92104 BOULOGNE BILLANCO,FRANCE
[2] HOP AMBROISE PARE,SERV CARDIOL,F-92104 BOULOGNE BILLANCO,FRANCE
来源
PRESSE MEDICALE | 1991年 / 20卷 / 10期
关键词
5-FLUOROURACIL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Major ventricular repolarization disorders without evidence of myocardial infarction developed in 2 patients during the first course of a 5-fluorouracil (5-FU) treatment in doses of 1 000 mg/m2/day. Anginal pain was present in one patient but not in the other. The electrical abnormalities persisted for more than 6 weeks in one case. Explorations carried out 2 and 6 weeks later respectively under calcium inhibitors showed absence of coronary artery stenosis, negative methylergonovine test (even after 5-FU infusion in one patient) and normal left ventricular kinetics. The mechanism of cardiac toxicity is discussed on the basis of these data: some elements support a coronary spasm and others direct myocardial toxicity.
引用
收藏
页码:458 / 460
页数:3
相关论文
共 50 条
  • [1] A case of 5-fluorouracil toxicity
    Fucile, C.
    Marini, V.
    Robbiano, L.
    Mattioli, F.
    Martelli, A.
    JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 2011, 84 (01): : 137 - 138
  • [2] Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene
    Ofverholm, Anna
    Arkblad, Eva
    Skrtic, Stanko
    Albertsson, Per
    Shubbar, Emman
    Enerback, Charlotta
    CLINICAL BIOCHEMISTRY, 2010, 43 (03) : 331 - 334
  • [3] Tiazofurin enhances the anabolism and toxicity of 5-fluorouracil
    Cysyk, RL
    Chisena, CA
    Hyman, R
    Monks, A
    CANCER LETTERS, 1996, 109 (1-2) : 49 - 55
  • [4] BIOLOGICAL MODELING OF 5-FLUOROURACIL DEVELOPMENTAL TOXICITY
    SHUEY, DL
    SETZER, RW
    LAU, C
    ZUCKER, RM
    ELSTEIN, KH
    NAROTSKY, MG
    KAVLOCK, RJ
    ROGERS, JM
    TOXICOLOGY, 1995, 102 (1-2) : 207 - 213
  • [5] Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity
    Foa, C
    Bondiau, PY
    Largillier, R
    Milano, G
    Magné, N
    REVUE DE MEDECINE INTERNE, 2000, 21 (12): : 1134 - 1135
  • [6] The reversible reproductive toxicity of 5-fluorouracil in mice
    Naren, Gerile
    Wang, Lu
    Zhang, Xiaolei
    Cheng, Lijuan
    Yang, Shuai
    Yang, Jiajie
    Guo, Jiaojiao
    Nashun, Buhe
    REPRODUCTIVE TOXICOLOGY, 2021, 101 : 1 - 8
  • [7] Cardiotoxicity of 5-fluorouracil: report of 6 cases
    Timour, Q
    Lombard-Bohas, C
    Slim, R
    Barel, C
    Bui-Xuan, B
    Tabib, A
    Bricca, G
    Malonne, H
    Vial, T
    Iordescu, D
    Descotes, J
    THERAPIE, 2002, 57 (03): : 302 - 306
  • [8] 5-FLUOROURACIL EXPOSURE DURING THE PERIOD OF CONCEPTION - REPORT ON 2 CASES
    ODOM, LD
    PLOUFFE, L
    BUTLER, WJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) : 76 - 77
  • [9] Pyrimidine degradation defects and severe 5-fluorouracil toxicity
    van Kuilenburg, ABP
    Meinsma, R
    van Gennip, AH
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9) : 1371 - 1375
  • [10] DERMATOLOGICAL TOXICITY FROM CHEMOTHERAPY CONTAINING 5-FLUOROURACIL
    LEO, S
    TATULLI, C
    TAVERI, R
    CAMPANELLA, GA
    CARRIERI, G
    COLUCCI, G
    JOURNAL OF CHEMOTHERAPY, 1994, 6 (06) : 423 - 426